Research ExplorerScientific StaffAlexander Stein

Alexander Stein

graph of relations
Affiliations
ORCID: 0000-0002-9768-0086

Publications

A Multimodal Lifestyle Psychosocial Survivorship Program in Young Cancer Survivors: The CARE for CAYA Program-A Randomized Clinical Trial Embedded in a Longitudinal Cohort Study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer-Results of the prospective multicenter PERMAD trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy

Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (118)

projects

Comprehensive Assessments and Related interventions to Enhance long-term outcome in Adolescents and Young Adults

Project: Research

110215 - Cholangiokarzinom

Project: Research

View all (2)